Technical Analysis for KPTI - Karyopharm Therapeutics Inc.

Grade Last Price % Change Price Change
C 1.47 -2.65% -0.04
KPTI closed down 2.65 percent on Monday, March 18, 2024, on 71 percent of normal volume.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Wide Bands Range Expansion 0.00%
Upper Bollinger Band Touch Strength 0.00%
MACD Bullish Signal Line Cross Bullish -2.65%
180 Bullish Setup Bullish Swing Setup -2.65%
Pocket Pivot Bullish Swing Setup -2.65%
Wide Bands Range Expansion -2.65%
Gapped Up Strength -2.65%
MACD Bearish Signal Line Cross Bearish 9.70%
20 DMA Support Bullish 9.70%

   Recent Intraday Alerts

Alert Time
Possible Pocket Pivot about 12 hours ago
Upper Bollinger Band Resistance about 15 hours ago
Rose Above Upper Bollinger Band about 16 hours ago
60 Minute Opening Range Breakout about 16 hours ago
Bullish 180 Entry about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Karyopharm Therapeutics Inc. Description

Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery and development of drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. The company's lead drug candidate includes Selinexor, an oral selective inhibitors of nuclear export (SINE) compound that specifically blocks XPO1 cargo binding is in Phase I clinical trials in patients with heavily pretreated relapsed and/or refractory hematological and solid tumor malignancies. Its other drug candidates comprise KPT-350 and related SINE compounds; PAK4 inhibitors; and Verdinexor, a SINE compound that is in Phase IIb clinical trials in pet dogs with newly-diagnosed or first relapse after chemotherapy lymphomas. The company was founded in 2008 and is based in Natick, Massachusetts.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Cancer Pharmaceutical Disease Treatment Of Cancer Oncology Lymphoma Chemotherapy Occupational Safety And Health Dog Stage Pharmaceutical Antibody Drug Conjugate

Is KPTI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.87
52 Week Low 0.6174
Average Volume 1,945,424
200-Day Moving Average 1.27
50-Day Moving Average 1.15
20-Day Moving Average 1.34
10-Day Moving Average 1.43
Average True Range 0.17
RSI (14) 56.90
ADX 24.27
+DI 26.64
-DI 15.03
Chandelier Exit (Long, 3 ATRs) 1.19
Chandelier Exit (Short, 3 ATRs) 1.59
Upper Bollinger Bands 1.60
Lower Bollinger Band 1.08
Percent B (%b) 0.75
BandWidth 38.46
MACD Line 0.08
MACD Signal Line 0.08
MACD Histogram -0.0002
Fundamentals Value
Market Cap 168.36 Million
Num Shares 115 Million
EPS -1.31
Price-to-Earnings (P/E) Ratio -1.12
Price-to-Sales 1.19
Price-to-Book 12.05
PEG Ratio -0.15
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.72
Resistance 3 (R3) 1.75 1.68 1.68
Resistance 2 (R2) 1.68 1.62 1.67 1.67
Resistance 1 (R1) 1.58 1.58 1.55 1.55 1.65
Pivot Point 1.51 1.51 1.50 1.50 1.51
Support 1 (S1) 1.41 1.45 1.38 1.39 1.29
Support 2 (S2) 1.34 1.41 1.33 1.27
Support 3 (S3) 1.24 1.34 1.26
Support 4 (S4) 1.22